Results showed that targets in the treatment of menstrual disorders are significantly associated with several biological pathways, such as VEGF and chemokine signaling pathways and alanine, aspartate, and glutamate metabolism, which are involved in the major pathological processes of menstrual disorders. Here, VEGFA is linked to Menstrual disorder.